Research Article
Efficacy and Safety of Treating Refractory Bone and Soft Tissue Sarcoma with Anlotinib in Different Treatment Patterns
Table 7
Treatment-related adverse events (
, %).
| | AEs | Grades 1–2 | Grades 3–4 | Total |
| | Hand-foot syndrome | 12 (27) | 1 (2) | 13 (30) | | Diarrhea | 8 (18) | 0 (0) | 8 (18) | | Hoarseness or sore throat | 7 (16) | 0 (0) | 7 (16) | | Vomit | 4 (9) | 0 (0) | 4 (9) | | Hypertension | 3 (7) | 1 (2) | 4 (9) | | Pleural effusion | 0 (0) | 2 (5) | 2 (5) | | Pneumothorax | 1 (2) | 2 (5) | 3 (7) | | Anemia | 0 (0) | 1 (2) | 1 (2) | | Hemoptysis | 0 (0) | 1 (2) | 1 (2) |
|
|